Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Biology Reports|October 12, 2012
Toll-like receptor 4 (TLR4) polymorphisms in Iranian patients with visceral leishmaniasisManoochehr Rasouli, Maryam Keshavarz, Mehdi Kalani, et al.Molecular Biology Reports|February 8, 2012
IL-1β (-511T/C) gene polymorphism not IL-1β (+3953T/C) and LT-α (+252A/G) gene variants confers susceptibility to visceral leishmaniasisAli Moravej, Manoochehr Rasouli, Mehdi Kalani, et al.Microbiology and Immunology|June 19, 2013
New immunological investigations on Helicobacter pylori-induced gastric ulcer in patientsHamid Reza Rahimi, Manoochehr Rasouli, Akram Jamshidzadeh, et al.Pharmaceutical Research|November 9, 2013
The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cellsShiguo Zhu, Cecele J Denman, Zehra S Cobanoglu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid TumorsApostolia M Tsimberidou, Philip A Beer, Carrie A Cartwright, et al.Oncoimmunology|August 15, 2025
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanomaMerve Hasanov, Simin Kiany, Marie-Andrée Forget, et al.European Urology|April 28, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 TrialsAlexander D Sherry, Van To, Criselle D'souza, et al.Journal of Neuro-Oncology|April 11, 2019
Correction to: Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRIBridget A Kennis, Keith A Michel, William B Brugmann, et al.Journal of Neuro-Oncology|February 22, 2019
Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRIBridget A Kennis, Keith A Michel, William B Brugmann, et al.Pageof 2